Sinil Pharmaceutical Statistics

Total Valuation

Sinil Pharmaceutical has a market cap or net worth of KRW 82.48 billion. The enterprise value is 52.38 billion.

Market Cap	82.48B
Enterprise Value	52.38B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Sinil Pharmaceutical has 11.38 million shares outstanding. The number of shares has decreased by -0.08% in one year.

Shares Outstanding	11.38M
Shares Change (YoY)	-0.08%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	34.48%
Owned by Institutions (%)	0.79%
Float	7.45M

Valuation Ratios

The trailing PE ratio is 5.32.

PE Ratio	5.32
Forward PE	n/a
PS Ratio	0.87
PB Ratio	0.60
P/FCF Ratio	5.14
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.35, with an EV/FCF ratio of 3.27.

EV / Earnings	3.32
EV / Sales	0.54
EV / EBITDA	2.35
EV / EBIT	3.15
EV / FCF	3.27

Financial Position

The company has a current ratio of 5.04, with a Debt / Equity ratio of 0.00.

Current Ratio	5.04
Quick Ratio	3.59
Debt / Equity	0.00
Debt / EBITDA	0.02
Debt / FCF	0.03
Interest Coverage	605.28

Financial Efficiency

Return on equity (ROE) is 11.76% and return on invested capital (ROIC) is 7.73%.

Return on Equity (ROE)	11.76%
Return on Assets (ROA)	6.81%
Return on Capital (ROIC)	7.73%
Revenue Per Employee	336.29M
Profits Per Employee	54.92M
Employee Count	287
Asset Turnover	0.63
Inventory Turnover	2.36

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +7.57% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+7.57%
50-Day Moving Average	7,495.60
200-Day Moving Average	7,306.85
Relative Strength Index (RSI)	47.30
Average Volume (20 Days)	28,248

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sinil Pharmaceutical had revenue of KRW 96.52 billion and earned 15.76 billion in profits. Earnings per share was 1,363.79.

Revenue	96.52B
Gross Profit	41.70B
Operating Income	16.61B
Pretax Income	17.94B
Net Income	15.76B
EBITDA	22.30B
EBIT	16.61B
Earnings Per Share (EPS)	1,363.79

Full Income Statement

Balance Sheet

The company has 30.56 billion in cash and 464.20 million in debt, giving a net cash position of 30.09 billion or 2,645.30 per share.

Cash & Cash Equivalents	30.56B
Total Debt	464.20M
Net Cash	30.09B
Net Cash Per Share	2,645.30
Equity (Book Value)	140.55B
Book Value Per Share	12,158.43
Working Capital	57.55B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 25.80 billion and capital expenditures -9.76 billion, giving a free cash flow of 16.04 billion.

Operating Cash Flow	25.80B
Capital Expenditures	-9.76B
Free Cash Flow	16.04B
FCF Per Share	1,409.79

Full Cash Flow Statement

Margins

Gross margin is 43.21%, with operating and profit margins of 17.21% and 16.33%.

Gross Margin	43.21%
Operating Margin	17.21%
Pretax Margin	18.59%
Profit Margin	16.33%
EBITDA Margin	23.11%
EBIT Margin	17.21%
FCF Margin	16.62%

Dividends & Yields

This stock pays an annual dividend of 170.00, which amounts to a dividend yield of 2.34%.

Dividend Per Share	170.00
Dividend Yield	2.34%
Dividend Growth (YoY)	70.00%
Years of Dividend Growth	3
Payout Ratio	12.47%
Buyback Yield	0.08%
Shareholder Yield	2.42%
Earnings Yield	18.81%
FCF Yield	19.45%

Dividend Details

Stock Splits

The last stock split was on December 28, 2022. It was a forward split with a ratio of 1.04.

Last Split Date	Dec 28, 2022
Split Type	Forward
Split Ratio	1.04

Scores

Sinil Pharmaceutical has an Altman Z-Score of 5.35.

Altman Z-Score	5.35
Piotroski F-Score	n/a